Skip to main content
Premium Trial:

Request an Annual Quote

MGI Tech, Pillar Biosciences Sign Comarketing Agreement for NGS Panels

NEW YORK – Pillar Biosciences said today that it has signed a comarketing agreement with China's MGI Tech for its Onco/Reveal next-generation sequencing panels.

Under the terms of the agreement, MGI, which markets the MGISP-960 and -100 automated high-throughput library prep systems, will market the Pillar panels to its sequencing customers outside the US.

"With MGI's sample prep automation, the hands-on time for our simplified library prep workflows has reached an unprecedented level of efficiency," Pillar CEO Gang Song said in a statement.

Boston-based Pillar said that its NGS panels featuring SLIMamp target enrichment chemistry are now compatible with the MGI, Illumina, and Thermo Fisher Scientific Ion Torrent sequencing platforms.

The comarketing deal is the second in as many weeks for MGI — the BGI subsidiary signed a similar deal with Twist Bioscience Oct. 30, covering target enrichment products in the Europe and Asia Pacific regions.

Pillar announced a strategic partnership and joint venture with China Biotech Services Holdings in January.

"This agreement combines two technologies that really complement each other," added MGI President Duncan Yu. "We're excited to work with Pillar to deliver seamlessly integrated automated library preparation."

The Scan

Panel Votes for COVID-19 Pill

A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says.

But Not Harm

New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare.

Effectiveness Drop Anticipated

Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports.

Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks

In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.